MSB 7.64% $1.48 mesoblast limited

Overwhelming efficacy - the stats required, page-187

  1. 12,373 Posts.
    lightbulb Created with Sketch. 1106
    Hi,
    . I dont think this trial is being run by the book.
    My feeling is the FDA have already tapped Grossman and SI on the shoulder to get product happening.

    Various reasons for expedited treatment , one big one, but the interview from those two seemed like they thought results were a given.The science involved points to positive trial as well.

    Might be wrong but one Bozo political future and a whole USA economy could hinge on Remestemcel
    and increased cell production.

    Aloha.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.